Blincyto
Blincyto market is segmented by region (country), players, by Type and by Application. Players, s ... Read More
Global and United States Blinatumomab Drugs Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Blinatumomab Drugs Product Introduction
1.2 Global Blinatumomab Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Blinatumomab Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Blinatumomab Drugs Sales in Volume for the Year 2017-2028
1.3 United States Blinatumomab Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Blinatumomab Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Blinatumomab Drugs Sales in Volume for the Year 2017-2028
1.4 Blinatumomab Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Blinatumomab Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Blinatumomab Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Blinatumomab Drugs Market Dynamics
1.5.1 Blinatumomab Drugs Industry Trends
1.5.2 Blinatumomab Drugs Market Drivers
1.5.3 Blinatumomab Drugs Market Challenges
1.5.4 Blinatumomab Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Blinatumomab Drugs Market Segment by Type
2.1.1 Prefilled
2.1.2 Non-prefilled
2.2 Global Blinatumomab Drugs Market Size by Type
2.2.1 Global Blinatumomab Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Blinatumomab Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Blinatumomab Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Blinatumomab Drugs Market Size by Type
2.3.1 United States Blinatumomab Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Blinatumomab Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Blinatumomab Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Blinatumomab Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Pharmacy
3.2 Global Blinatumomab Drugs Market Size by Application
3.2.1 Global Blinatumomab Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Blinatumomab Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Blinatumomab Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Blinatumomab Drugs Market Size by Application
3.3.1 United States Blinatumomab Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Blinatumomab Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Blinatumomab Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Blinatumomab Drugs Competitor Landscape by Company
4.1 Global Blinatumomab Drugs Market Size by Company
4.1.1 Top Global Blinatumomab Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Blinatumomab Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Blinatumomab Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Blinatumomab Drugs Price by Manufacturer (2017-2022)
4.2 Global Blinatumomab Drugs Concentration Ratio (CR)
4.2.1 Blinatumomab Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Blinatumomab Drugs in 2021
4.2.3 Global Blinatumomab Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Blinatumomab Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Blinatumomab Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Blinatumomab Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Blinatumomab Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Blinatumomab Drugs Market Size by Company
4.5.1 Top Blinatumomab Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Blinatumomab Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Blinatumomab Drugs Sales by Players (2020, 2021 & 2022)
5 Global Blinatumomab Drugs Market Size by Region
5.1 Global Blinatumomab Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Blinatumomab Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Blinatumomab Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Blinatumomab Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Blinatumomab Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Blinatumomab Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Blinatumomab Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Blinatumomab Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Blinatumomab Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Blinatumomab Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Blinatumomab Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Blinatumomab Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Blinatumomab Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Blinatumomab Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Blinatumomab Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Blinatumomab Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Blinatumomab Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Amgen
7.1.1 Amgen Corporation Information
7.1.2 Amgen Description and Business Overview
7.1.3 Amgen Blinatumomab Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Amgen Blinatumomab Drugs Products Offered
7.1.5 Amgen Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Blinatumomab Drugs Industry Chain Analysis
8.2 Blinatumomab Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Blinatumomab Drugs Distributors
8.3 Blinatumomab Drugs Production Mode & Process
8.4 Blinatumomab Drugs Sales and Marketing
8.4.1 Blinatumomab Drugs Sales Channels
8.4.2 Blinatumomab Drugs Distributors
8.5 Blinatumomab Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Blinatumomab Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Blinatumomab Drugs Market Trends
Table 3. Blinatumomab Drugs Market Drivers
Table 4. Blinatumomab Drugs Market Challenges
Table 5. Blinatumomab Drugs Market Restraints
Table 6. Global Blinatumomab Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Blinatumomab Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Blinatumomab Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Blinatumomab Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Blinatumomab Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Blinatumomab Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Blinatumomab Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Blinatumomab Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Blinatumomab Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Blinatumomab Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Blinatumomab Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Blinatumomab Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blinatumomab Drugs as of 2021)
Table 18. Top Players of Blinatumomab Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Blinatumomab Drugs Product Type
Table 20. Date of International Manufacturers Enter into Blinatumomab Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Blinatumomab Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Blinatumomab Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Blinatumomab Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Blinatumomab Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Blinatumomab Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Blinatumomab Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Blinatumomab Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Blinatumomab Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Blinatumomab Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Blinatumomab Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Blinatumomab Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Blinatumomab Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Blinatumomab Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Blinatumomab Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Blinatumomab Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Blinatumomab Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Blinatumomab Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Blinatumomab Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Blinatumomab Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Blinatumomab Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Amgen Corporation Information
Table 43. Amgen Description and Business Overview
Table 44. Amgen Blinatumomab Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Amgen Blinatumomab Drugs Product
Table 46. Amgen Recent Development
Table 47. Key Raw Materials Lists
Table 48. Raw Materials Key Suppliers Lists
Table 49. Blinatumomab Drugs Customers List
Table 50. Blinatumomab Drugs Distributors List
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Blinatumomab Drugs Product Picture
Figure 2. Global Blinatumomab Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Blinatumomab Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Blinatumomab Drugs Sales 2017-2028 (K Units)
Figure 5. United States Blinatumomab Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Blinatumomab Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Blinatumomab Drugs Sales 2017-2028 (K Units)
Figure 8. United States Blinatumomab Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Blinatumomab Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Blinatumomab Drugs Report Years Considered
Figure 11. Product Picture of Prefilled
Figure 12. Product Picture of Non-prefilled
Figure 13. Global Blinatumomab Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Blinatumomab Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Blinatumomab Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Blinatumomab Drugs Sales by Type (2017-2028) & (K Units)
Figure 17. Global Blinatumomab Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Blinatumomab Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Blinatumomab Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Blinatumomab Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Blinatumomab Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Blinatumomab Drugs Sales by Type (2017-2028) & (K Units)
Figure 23. United States Blinatumomab Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Blinatumomab Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Hospital
Figure 26. Product Picture of Pharmacy
Figure 27. Global Blinatumomab Drugs Market Share by Application in 2022 & 2028
Figure 28. Global Blinatumomab Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global Blinatumomab Drugs Sales Market Share in Value by Application (2017-2028)
Figure 30. Global Blinatumomab Drugs Sales by Application (2017-2028) & (K Units)
Figure 31. Global Blinatumomab Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global Blinatumomab Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 33. United States Blinatumomab Drugs Market Share by Application in 2022 & 2028
Figure 34. United States Blinatumomab Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States Blinatumomab Drugs Sales Market Share in Value by Application (2017-2028)
Figure 36. United States Blinatumomab Drugs Sales by Application (2017-2028) & (K Units)
Figure 37. United States Blinatumomab Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States Blinatumomab Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Blinatumomab Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 40. North America Blinatumomab Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe Blinatumomab Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. Europe Blinatumomab Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific Blinatumomab Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Asia-Pacific Blinatumomab Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Blinatumomab Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 63. Latin America Blinatumomab Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Blinatumomab Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Middle East & Africa Blinatumomab Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. UAE Blinatumomab Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Blinatumomab Drugs Value Chain
Figure 73. Blinatumomab Drugs Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen